文献速递糖尿病

新诊断糖尿病视网膜病变患者的失明风险

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy.
PubMed 文献 · Diabetes Care · 2021-01-20

该回顾性队列研究基于美国IRIS眼科注册数据库,纳入2013至2017年新诊断糖尿病视网膜病变且视力良好(20/40或更好)的成年患者眼,评估初始病变严重程度与持续性失明的关系。中位随访662.5天,53,535只眼中678只(1.3%)发生持续性失明。初始诊断为增殖性糖尿病视网膜病变的眼在2年后发生持续性失明的可能性是轻度非增殖性病变的4.0倍,校正后风险比为2.26(95%CI 2.09-2.45)。

要点

  • 新诊断糖尿病视网膜病变时病变越重,持续性失明风险越高。
  • 增殖性病变眼2年持续性失明风险是轻度非增殖病变的4.0倍。
  • 即使初始视力良好,重度病变仍需警惕失明风险。

核心结论

  • 在新诊断糖尿病视网膜病变且视力良好的眼中,初始病变越严重,发生持续性失明的风险显著增加。

主要发现

  • 53,535只眼中678只(1.3%)发生持续性失明。
  • 初始为增殖性糖尿病视网膜病变的眼占分析人群的10.5%(5,629/53,535),但占发生持续性失明眼的26.5%(180/678)。
  • Kaplan-Meier分析显示,初始为中度和重度非增殖性病变及增殖性病变的眼在诊断后2年发生持续性失明的可能性分别是初始轻度病变眼的2.6、3.6和4.0倍。
  • 校正初始特征及随访期间眼部疾病发展后,增殖性病变眼相比轻度非增殖病变眼发生持续性失明的风险比为2.26(95%CI 2.09-2.45)。

关键数值与推荐

  • 持续性失明定义为研究眼在间隔至少3个月的两个独立访视中Snellen视力为20/200或更差,且未改善至优于20/100。
  • 初始病变严重程度分为轻度非增殖性、中度非增殖性、重度非增殖性和增殖性糖尿病视网膜病变。

临床怎么用

  • 对新诊断糖尿病视网膜病变患者,应根据初始病变严重程度评估失明风险,尤其对中重度非增殖性或增殖性病变者加强监测和干预。

局限性

  • 本研究为回顾性注册数据库分析,可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between initial diabetic retinopathy (DR) severity/risk of blindness in patients with newly diagnosed DR/good vision in the U.S. RESEARCH DESIGN AND METHODS: This retrospective cohort study evaluated adult patients with good vision (20/40 or better) and newly diagnosed DR between 1 January 2013 and 31 December 2017 (index date) in the American Academy of Ophthalmology's Intelligent Research in Sight (IRIS) Registry. The primary exposure of interest was DR severity at index: mild nonproliferative DR (NPDR), moderate NPDR, severe NPDR, and proliferative DR (PDR). The main outcome measure was development of sustained blindness (SB), defined as study eyes with Snellen visual acuity readings of 20/200 or worse at two separate visits ≥3 months apart that did not improve beyond 20/100. RESULTS: Among 53,535 eligible eyes (mean follow-up 662.5 days), 678 (1.3%) eyes developed SB. Eyes with PDR at index represented 10.5% (5,629 of 53,535) of the analysis population but made up 26.5% (180 of 678) of eyes that developed SB. Kaplan-Meier analysis revealed that eyes with moderate NPDR, severe NPDR, and PDR at index were 2.6, 3.6, and 4.0 times more likely, respectively, to develop SB after 2 years of DR diagnosis versus eyes with mild DR at index. In a Cox proportional hazards model adjusted for index characteristics/development of ocular conditions during follow-up, eyes with PDR had an increased risk of developing SB versus eyes with mild NPDR at index (hazard ratio 2.26 [95% CI 2.09-2.45]). CONCLUSIONS: In this longitudinal ophthalmologic registry population involving eyes with good vision, more advanced DR at first diagnosis was a significant risk factor for developing SB.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wykoff CC, Khurana RN, Nguyen QD, et al. Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy. Diabetes Care. 2021. PMID: 33472864. doi:10.2337/dc20-0413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。